Organometallics
Article
(CD3CN): δ 2.22 (s, 3 H, MeCN), 3.71 (s, 3 H, OMe), 3.94 (dt, J ≈
Compound 8b. This compound was prepared similarly from 4b
3
(158 mg, 0.2 mmol) and Ag[PF6] (101 mg, 0.4 mmol) and isolated as
1.3, 2.5 Hz, 1 H, fc), 3.96 (d, JHH = 6.1 Hz, 1 H, NHCH2), 3.98 (d,
1
3JHH = 6.1 Hz, 1 H, NHCH2), 4.06 (dt, J ≈ 1.3, 2.5 Hz, 1 H, fc), 4.14
(m, 1 H, fc), 4.60 (dt, J ≈ 1.3, 2.6 Hz, 1 H, fc), 4.66 (m, 2 H, fc), 4.72
a yellow solid. Yield: 122 mg (56%). H NMR (CD3CN): δ 1.07 (d,
3JHH = 6.9 Hz, 6 H, CHMe2), 1.93 (s, 3 H, η6-C6H4Me), 2.29 (s, 6 H,
MeCN), 2.49 (sept, 3JHH = 6.9 Hz, 1 H, CHMe2), 3.70 (s, 3 H, OMe),
3.97 (d, 3JHH = 6.1 Hz, 2 H, NHCH2), 4.12 (vt, 2 H, fc), 4.31 (vq, 2 H,
(m, 1 H, fc), 4.82 (m, 1 H, fc), 5.64 (s, 6 H, η6-C6H6), 6.99 (t, 3JHH
=
6.0 Hz, 1 H, NHCH2), 7.51−7.83 (m, 10 H, PPh2). 31P{1H} NMR
3
1
fc), 4.67 (vt, 2 H, fc), 4.85 (vq, 2 H, fc), 5.65 (d, JHH = 6.5 Hz, 2 H,
(CD3CN): δ −144.6 (sept, JPF = 706 Hz, PF6), 28.1 (s, PPh2).
3
3
η6-C6H4), 5.81 (d, JHH = 6.5 Hz, 2 H, η6-C6H4), 6.91 (t, JHH = 6.0
19F{1H} NMR (CD3CN): δ −72.9 (d, 1JPF = 706 Hz, PF6). IR (KBr):
νNH 3442 m, νCN 2296 w, νCO 1748 vs, amide I 1651 vs, amide II
1534 vs, νPF 842 vs cm−1. MS (ESI+): m/z 700 ([M − MeCN −
PF6]+). Anal. Calcd for C34H33N2O3F6P2ClFeRu·0.75CHCl3: C, 42.79;
H, 3.49; N, 2.87. Found: C, 42.84; H, 3.48; N, 2.91.
Hz, 1 H, NHCH2), 7.65−7.81 (m, 10 H, PPh2). 31P{1H} NMR
1
(CD3CN): δ −144.6 (sept, JPF = 707 Hz, PF6), 33.0 (s, PPh2).
19F{1H} NMR (CD3CN): δ −72.8 (d, 1JPF = 707 Hz, PF6). IR (KBr):
νNH 3414 m, νCN 2329 w and 2299 w, νCO 1747 s, amide I 1638 vs,
amide II 1542 s, νPF 835 vs cm−1. MS (ESI+): m/z 948 ([M − PF6]+).
Compound 8c. Following the general procedure, 4c (164 mg, 0.2
mmol) and Ag[PF6] (101 mg, 0.4 mmol) afforded 8c as a yellow solid.
Yield: 123 mg, 55%. 1H NMR (CD3CN): δ 1.87 (s, 18 H, η6-C6Me6),
2.35 (s, 6 H, MeCN), 3.70 (s, 3 H, OMe), 3.96 (vt, 2 H, fc), 3.97 (d,
3JHH = 6.1 Hz, 2 H, NHCH2), 4.41 (vq, 2 H, fc), 4.63 (vt, 2 H, fc),
Compound 7b. This compound was prepared similarly from [(η6-
p-cymene)Ru(MeCN)2Cl][PF6] (100 mg, 0.2 mmol) and 1 (97 mg,
0.2 mmol). Yield: 132 mg (65%), yellow solid. 1H NMR (CD3CN): δ
3
3
0.99 (d, JHH = 6.9 Hz, 3 H, CHMe2), 1.00 (d, JHH = 6.9 Hz, 3 H,
CHMe2), 1.90 (s, 3 H, η6-C6H4Me), 2.15 (s, 3 H, MeCN), 2.35 (sept,
3JHH = 7.0 Hz, 1 H, CHMe2), 3.70 (s, 3 H, OMe), 3.85 (dt, J ≈ 1.3, 2.5
Hz, 1 H, fc), 3.93 (dt, J ≈ 1.3, 2.6 Hz, 1 H, fc), 3.95 (d, 3JHH = 6.1 Hz,
2 H, NHCH2), 4.00 (m, 1 H, fc), 4.47 (dt, J ≈ 1.4, 2.6 Hz, 1 H, fc),
4.61 (dt, J ≈ 1.3, 2.6 Hz, 1 H, fc), 4.63 (m, 1 H, fc), 4.73 (m, 2 H, fc),
5.17 (d, JHH = 6.1 Hz, 1 H, η6-C6H4), 5.43 (dt, JHH = 6.2, 1.4 Hz, 1 H,
η6-C6H4), 5.50 (d, JHH = 6.5 Hz, 1 H, η6-C6H4), 5.74 (dd, JHH = 6.4,
3
4.83 (vq, 2 H, fc), 6.90 (t, JHH = 6.1 Hz, 1 H, NHCH2), 7.63−7.78
(m, 10 H, PPh2). 31P{1H} NMR (CD3CN): δ −144.6 (sept, 1JPF = 707
Hz, PF6), 34.6 (s, PPh2). 19F{1H} NMR (CD3CN): δ −72.9 (d, 1JPF
=
706 Hz, PF6). IR (KBr): νNH 3444 m, νCN 2327 w and 2295 w, νCO
1747 vs, amide I 1639 vs, amide II 1542 vs, νPF 839 vs cm−1. MS (ESI
+): m/z 976 ([M − PF6]+), 748 ([(C6Me6)Ru(1 − H)]+).
3
1.0 Hz, 1 H, η6-C6H4), 6.89 (t, JHH = 6.1 Hz, 1 H, NHCH2), 7.55−
1
7.94 (m, 10 H, PPh2). 31P{1H} NMR (CD3CN): δ −144.6 (sept, JPF
X-ray Crystallography. The diffraction data were collected with a
Stoe image plate diffraction system equipped with a ϕ circle
goniometer, using Mo Kα graphite-monochromated radiation (λ =
= 706 Hz, PF6), 27.7 (s, PPh2). 19F{1H} NMR (CD3CN): δ −72.9 (d,
1JPF = 706 Hz, PF6). IR (KBr): νNH 3418 s, νCN 2293 w, νCO 1750 s,
amide I 1651 s, amide II 1533 s, νPF 840 vs cm−1. MS (ESI+): m/z 756
0.710 73 Å; ϕ range 0−200°, 2θ range from 3.0 to 59°, Dmax − Dmin
=
12.45−0.81 Å). The structures were solved by direct methods using
the program SHELXS-97.32 Refinement and all further calculations
were carried out using SHELXL-97.32 Examination of the structures
with PLATON33 reveals in 4b additional disordered solvent molecules,
while in 8b voids between anions and cations are observed. Therefore,
new data sets corresponding to omission of the missing solvent
molecules were generated with the SQUEEZE algorithm34 and the
structures were refined to full convergence. In both structures, the
hydrogen atoms were included in their calculated positions and treated
as riding atoms using the SHELXL default parameters. The non-
hydrogen atoms were refined anisotropically, using weighted full-
matrix least squares based on F2. Crystallographic details are available
as Supporting Information (Table S4). The figures were drawn with
the PLATON program. The same program was used to perform all
geometric calculations.
( [ M
−
M e C N
−
P F 6 ]
+ ) . A n a l . C a l c d f o r
C38H41N2O3F6P2ClFeRu·0.55CHCl3: C, 45.95; H, 4.16; N, 2.78.
Found: C, 55.97; H, 4.11; N, 2.70.
Compound 7c. Starting with [(η6-hexamethylbenzene)Ru-
(MeCN)2Cl][PF6] (105 mg, 0.2 mmol) and 1 (97 mg, 0.2 mmol),
the general procedure afforded 7c as a yellow solid. Yield: 150 mg
(70%). 1H NMR (CD3CN): δ 1.76 (s, 18 H, η6-C6Me6), 2.16 (s, 3 H,
MeCN), 3.68 (m, 1 H, fc), 3.70 (s, 3 H, OMe), 3.75 (m, 1 H, fc), 3.96
(br d, 3JHH = 6.1 Hz, 2 H, NHCH2), 4.28 (br s, 1 H, fc), 4.62 (m, 1 H,
fc), 4.50 (m, 2 H, fc), 4.64 (m, 1 H, fc), 4.72 (m, 1 H, fc), 6.92 (t, 3JHH
= 5.9 Hz, 1 H, NHCH2), 7.50−7.85 (m, 10 H, PPh2). 31P{1H} NMR
1
(CD3CN): δ −144.6 (sept, JPF = 706 Hz, PF6), 29.7 (s, PPh2).
19F{1H} NMR (CD3CN): δ −72.9 (d, 1JPF = 706 Hz, PF6). IR (KBr):
νNH 3440 m, νCN 2289 w, νCO 1749 vs, amide I 1653 vs, amide II
1534 vs, νPF 847 vs cm−1. MS (ESI+): m/z 784 ([M − MeCN −
PF6]+). Anal. Calcd for C40H45N2O3F6P2ClFeRu·0.9CHCl3: C, 45.59;
H, 4.29; N, 2.60. Found: C, 45.48; H, 4.28; N, 2.75.
CCDC-866729 (4b·2CH3OH) and CCDC-866730 (8b) contain
the supplementary crystallographic data for this paper. These data can
html (or from the Cambridge Crystallographic Data Centre, 12, Union
Road, Cambridge CB2 1EZ, U.K.; fax, (internat.) +44-1223/336-033;
General Procedure for the Oxidation of Secondary Alcohols.
The appropriate quantities of the catalyst and alcohol (1 mmol) were
mixed with water (4 mL) in an open vial. The oxidizing agent (4
mmol) was added slowly, and the resulting mixture was stirred at room
temperature for the given reaction time. Then, it was extracted with
diethyl ether (2 × 5 mL) and dried over anhydrous MgSO4. A small
aliquot was analyzed by 1H NMR spectroscopy to determine the
conversion. In the case of complete conversion, the extracts were
evaporated and the crude product was isolated by flash column
chromatography over silica using a hexane/diethyl ether mixture to
give pure ketones following evaporation.
Characterization Data of the Oxidation Products. Acetophe-
none:35 1H NMR (CDCl3) δ 2.61 (s, 3 H, Me), 7.43−7.50 (m, 2 H,
C6H5), 7.52−7.61 (m, 1 H, C6H5), 7.93−7.98 (m, 2 H, C6H5). 4′-
Fluoroacetophenone:34 1H NMR (CDCl3) δ 2.59 (s, 3 H, Me), 7.09−
7.16 (m, 2 H, C6H4), 7.96−8.01 (m, 2 H, C6H4). 4′-Chloroacetophe-
none:34 1H NMR (CDCl3) δ 2.59 (s, 3 H, Me), 7.41−7.47 (m, 2 H,
C6H4), 7.88−7.92 (m, 2 H, C6H4). 4′-Bromoacetophenone (ref.34): 1H
NMR (CDCl3) δ 2.58 (s, 3 H, Me), 7.58−7.62 (m, 2 H, C6H4), 7.79−
7.84 (m, 2 H, C6H4). 4′-Methylacetophenone:34 1H NMR (CDCl3) δ
2.42 (s, 3 H, MeC6H4), 2.59 (s, 3 H, Me), 7.23−7.28 (m, 2 H, C6H4),
General Procedure for the Synthesis of Compounds [(η6-
arene)Ru(MeCN)2(1-κP)][PF6]2 (8). A solution of the respective
complex [(η6-arene)RuCl2(1-κP)] (4; 1 equiv) in acetonitrile (2 mL
per 0.1 mmol of Ru complex) was treated with the stoichiometric
amount of Ag[PF6] (2 equiv) dissolved in acetonitrile (3 mL per 0.2
mmol of Ag salt). The resulting yellow-orange reaction mixture was
stirred at room temperature for 3 h, the precipitated solid (AgCl) was
removed by filtration through a PTFE filter, and the filtrate was
evaporated under vacuum. The residue was purified by preparative
thin-layer chromatography on SiO2 with CHCl3/acetonitrile (2/1 v/v)
as the eluent. When they are analyzed by conventional elemental
analysis, the bis(acetonitrile) complexes 8 notoriously give erratic
results, very likely due to incomplete combustion.
Compound 8a. Starting from 4a (147 mg, 0.2 mmol) and Ag[PF6]
(101 mg, 0.4 mmol), the general procedure afforded 8a as a yellow
solid. Yield: 92 mg, 44%. 1H NMR (CD3CN): δ 2.23 (s, 6 H, MeCN),
3.70 (s, 3 H, OMe), 3.98 (d, 3JHH = 6.1 Hz, 2 H, NHCH2), 4.21 (vt, 2
H, fc), 4.36 (vq, 2 H, fc), 4.73 (vt, 2 H, fc), 4.90 (vq, 2 H, fc), 5.94 (s,
3
6 H, η6-C6H6), 6.95 (t, JHH = 6.0 Hz, 1 H, NHCH2), 7.60−7.77 (m,
10 H, PPh2). 31P{1H} NMR (CD3CN): δ −144.6 (sept, 1JPF = 707 Hz,
PF6), 33.7 (s, PPh2). 19F{1H} NMR (CD3CN): δ −72.8 (d, 1JPF = 706
Hz, PF6). IR (KBr): νNH 3417 m, νCN 2330 w and 2302 w, νCO 1748
s, amide I 1639 s, amide II 1542 s, νPF 836 vs cm−1. MS (ESI+): m/z
586 ([(C6H6)Ru(1 − H)]+).
3992
dx.doi.org/10.1021/om3002087 | Organometallics 2012, 31, 3985−3994